Actively Recruiting
Giessen Pulmonary Hypertension in Lung Cancer Registry
Led by University of Giessen · Updated on 2025-04-01
500
Participants Needed
1
Research Sites
1021 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.
CONDITIONS
Official Title
Giessen Pulmonary Hypertension in Lung Cancer Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with lung cancer at the University of Giessen Lung Cancer Center
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University hospital Giessen
Giessen, Hesse, Germany, 35392
Actively Recruiting
Research Team
B
Bastian Eul, MD
CONTACT
M
Michael John Cekay, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here